RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Clinical trial NCT04762225 · TERMINATED

Trial details

NCT number: NCT04762225
Sponsor: Repertoire Immune Medicines
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Melanoma Cervical Cancer

Start date: 2021-05-10
Primary completion: 2022-09-14
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.